Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy. Here, CD47 is linked to thyroid gland undifferentiated (anaplastic) carcinoma.